SCHEMBL28417929

SCHEMBL28417929

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(C(=O)CN4CCN(C(=O)O)CC4)ccc3OCC)nc12

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 19/20 0.82
PDE6C P51160 3/20 0.82
HDAC1 Q13547 11/20 0.63
HDAC6 Q9UBN7 11/20 0.63
HDAC2 Q92769 7/20 0.63
PDE3B Q13370 3/20 0.62
PDE3A Q14432 3/20 0.62
HDAC3 O15379 1/20 0.61
NCOR2 Q9Y618 1/20 0.61
KMT2A Q03164 2/20 0.59
PDE1A P54750 2/20 0.59
PDE1B Q01064 2/20 0.59
PDE1C Q14123 2/20 0.59
MEN1 O00255 1/20 0.59
ALDH1A1 P00352 1/20 0.59
HPGD P15428 1/20 0.59
PDE2A O00408 1/20 0.59
ABCC4 O15439 1/20 0.59
ABCC5 O15440 1/20 0.59
PDE6D O43924 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7920627 0.94 PDE5A (0.82) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL29357402 0.93 PDE5A (0.85) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL2693448 0.93 PDE5A (0.85) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL30199753 0.93 PDE5A (0.85) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL25013469 0.93 PDE5A (0.85) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL28482244 0.92 PDE5A (0.83) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL7964961 0.92 PDE5A (0.85) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL7965731 0.91 PDE5A (0.84) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL147337 0.90 PDE5A (1.00) PDE5APDE6CHDAC1HDAC6HDAC2
SCHEMBL18069561 0.88 PDE5A (0.77) PDE5APDE6CHDAC1HDAC6HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN claimed
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN disclosed